Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | SF Stifel Financial Corp | 13G/A | 10.18% | Mar 28, 2024 | 2y |
| VANGUARD GROUP INC | EXPO Exponent Inc | 13G/A | 10.46% | Mar 28, 2024 | 2y |
| VANGUARD GROUP INC | SEM Select Medical Holdings Corp | 13G/A | 10.13% | Mar 28, 2024 | 2y |
| VANGUARD GROUP INC | CRGY Crescent Energy Co | 13G/A | 10.16% | Mar 28, 2024 | 2y |
| VANGUARD GROUP INC | MGY Magnolia Oil & Gas Corp | 13G/A | 11.38% | Mar 28, 2024 | 2y |
| VANGUARD GROUP INC | DOW Dow Inc. | 13G/A | 10.22% | Mar 28, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | LABP Landos Biopharma, Inc. Common Stock | 13D/A | 47.7% | Mar 24, 2024 | 2y |
| Xontogeny, LLC | LABP Landos Biopharma, Inc. Common Stock | 13D/A | 9.9% | Mar 24, 2024 | 2y |
| SPX Gestao de Recursos Ltda | VSTA Vasta Platform Limited Class A Ordinary Shares | 13G | 7.5% | Mar 6, 2024 | 2y |
| Walleye Capital LLC | PPYA Papaya Growth Opportunity Corp. I Class A Common Stock | 13G/A | 3.63% | Feb 29, 2024 | 2y |
| Northern Star II Sponsor LLC | NSTB Northern Star Investment Corp. II | 13D/A | 84% | Apr 8, 2024 | 2y |
| SCHULER JACK W | BDSX Biodesix Inc | 13D/A | 27.2% | Apr 5, 2024 | 2y |
| Matthew Strobeck | BDSX Biodesix Inc | 13D/A | 4.98% | Apr 5, 2024 | 2y |
| Venu Raman Kumar | AERT Aeries Technology, Inc. | 13D/A | 73.8% | Apr 5, 2024 | 2y |
| Monte M. Brem | STEP StepStone Group Inc. | 13D/A | 48.9% | Apr 5, 2024 | 2y |
| Fosun International Ltd | LANV Lanvin Group Holdings Ltd | 13D/A | 58.65% | Apr 5, 2024 | 2y |
| Lawrence T. Kennedy, Jr. | BDSX Biodesix Inc | 13D/A | 18.7% | Apr 5, 2024 | 2y |
| John Patience | BDSX Biodesix Inc | 13D/A | 6.7% | Apr 5, 2024 | 2y |
| CVI Investments, Inc. | TARA Protara Therapeutics, Inc. | 13G | 5.3% | Apr 5, 2024 | 2y |
| Beaver Hollow Wellness, LLC | SVT Servotronics, Inc. | 13D/A | 16.9% | Apr 5, 2024 | 2y |
| Bhisham Khare | AERT Aeries Technology, Inc. | 13D/A | 4.4% | Apr 5, 2024 | 2y |
| Gregory George | MESO Mesoblast Ltd | 13G/A | 13.8% | Apr 5, 2024 | 2y |
| Kimmeridge Energy Management Company, LLC | SBOW SilverBow Resources, Inc. | 13D/A | 12.9% | Apr 5, 2024 | 2y |
| Gregory Tamkin | MOVE Corvex, Inc. | 13G/A | 7.66% | Apr 4, 2024 | 2y |
| Avidity Partners Management LP | ORKA Oruka Therapeutics, Inc. | 13G | 6.9% | Apr 3, 2024 | 2y |
| Mo Chen | TSPH TuSimple Holdings Inc. | 13D/A | 19.1% | Apr 3, 2024 | 2y |
| James N. Topper | ELEV Elevation Oncology, Inc. Common stock | 13G | 6.1% | Apr 2, 2024 | 2y |
| Mubadala Investment Co PJSC | EDR Endeavor Group Holdings, Inc. | 13D | 0.7% | Apr 2, 2024 | 2y |
| Bayer HealthCare LLC | BOLD Boundless Bio, Inc. | 13G | 7.3% | Apr 2, 2024 | 2y |
| Phoenix Financial Ltd. | TEVA Teva Pharmaceutical Industries Ltd | 13G/A | 4.83% | Apr 1, 2024 | 2y |
| Phoenix Financial Ltd. | WILCF G Willi Food International Ltd | 13G/A | 4.9% | Apr 1, 2024 | 2y |
| Phoenix Financial Ltd. | MATW Matthews International Corp | 13G/A | 4.77% | Apr 1, 2024 | 2y |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | FOXF Fox Factory Holding Corp | 13G/A | 10.09% | Mar 31, 2024 | 2y |
| Konstantakopoulos, Konstantinos | SHIP Seanergy Maritime Holdings Corp. | 13G/A | 4.98% | Mar 31, 2024 | 2y |
| SG Americas Securities, LLC | RYAAY Ryanair Holdings PLC | 13G | 5.89% | Mar 31, 2024 | 2y |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | DAVA Endava plc | 13G/A | 10.28% | Mar 31, 2024 | 2y |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | THO Thor Industries Inc | 13G/A | 10.01% | Mar 31, 2024 | 2y |
| COMPASS GROUP LLC | VSTA Vasta Platform Limited Class A Ordinary Shares | 13G/A | 11.9% | Mar 31, 2024 | 2y |
| JPMORGAN CHASE & CO | NSC Norfolk Southern Corp | 13G/A | 3.6% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | RYN Rayonier Inc | 13G/A | 4.4% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | RVNC Revance Therapeutics, Inc. | 13G/A | 2.6% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | III Information Services Group Inc. | 13G/A | 4% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | STEP StepStone Group Inc. | 13G/A | 4.3% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | GEL Genesis Energy LP | 13G/A | 4.4% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | EVH Evolent Health, Inc. | 13G/A | 4% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | KIM Kimco Realty Corp | 13G/A | 4.3% | Mar 29, 2024 | 2y |
| JPMORGAN CHASE & CO | PMVP PMV Pharmaceuticals, Inc. | 13G/A | 0% | Mar 29, 2024 | 2y |
| Karpus Management, Inc. | AFJK Aimei Health Technology Co., Ltd. | 13G | 12.19% | Mar 28, 2024 | 2y |
| Karpus Management, Inc. | ESHA ESH Acquisition Corp. | 13G/A | 4.21% | Mar 28, 2024 | 2y |
| Karpus Management, Inc. | LBBB Lakeshore Acquisition II Corp. Ordinary Shares | 13G/A | 0% | Mar 28, 2024 | 2y |